Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Total Debt (2019 - 2020)

Historic Total Debt for aTYR PHARMA (ATYR) over the last 2 years, with Q3 2020 value amounting to $3.1 million.

  • aTYR PHARMA's Total Debt fell 7108.45% to $3.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $3.1 million, marking a year-over-year decrease of 7108.45%. This contributed to the annual value of $8.7 million for FY2019, which is N/A changed from last year.
  • According to the latest figures from Q3 2020, aTYR PHARMA's Total Debt is $3.1 million, which was down 7108.45% from $5.0 million recorded in Q2 2020.
  • aTYR PHARMA's 5-year Total Debt high stood at $14.2 million for Q1 2019, and its period low was $3.1 million during Q3 2020.